Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects

Background  Recombinant (rec-) coagulation factor VIII concentrates available for hemophilia A (HA) treatment differ in cell line production and structure, which could affect their pharmacodynamics and immunogenicity. Clinical trials showed that previously untreated patients with severe HA present h...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:TH Open
Hoofdauteurs: De Cristofaro, Raimondo, Sacco, Monica, Lancellotti, Stefano, Berruti, Federico, Garagiola, Isabella, Valsecchi, Carla, Basso, Maria, Di Stasio, Enrico, Peyvandi, Flora
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Georg Thieme Verlag KG 2019
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524925/
https://ncbi.nlm.nih.gov/pubmed/31249992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1688413
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items